For citations:
Ivashchenko T.A., Romanenko Ya.O., Kartseva A.S., Silkina M.V., Mar’in M.A., Khlyntseva A.E., Zeninskaya N.A., Shemyakin I.G., Firstova V.V. Monoclonal Antibodies Capable of Inhibiting the Interaction of the Receptor Binding Domain of SARS-CoV-2 Virus with the Angiotensin-Converting Receptor 2 of Human Cells. Problems of Particularly Dangerous Infections. 2024;(3):111-117. (In Russ.) https://doi.org/10.21055/0370-1069-2024-3-111-117
Email this article 